Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2017-03-13 2017-03-13
Drug Identification Number 00626600 00626600
Brand name ODAN-SPOR-HC ODAN-SPOR-HC
Common or Proper name Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate
Strength(s) 10 mg/mL 3.5 mg/mL 10,000 unit/mL 10 mg/mL 3.5 mg/mL 10,000 unit/mL
Dosage form(s) Suspension Suspension
Route of administration Otic Otic
Packaging size 10 mL 10 mL
ATC code S02CA S02CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-04-15 2016-04-15
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments